饶毅的个人博客分享 http://blog.sciencenet.cn/u/饶毅      


张亭栋等砒霜治疗白血病的部分论文 Papers by T Zhang et al 精选

已有 33190 次阅读 2013-2-1 10:06 |个人分类:科学|系统分类:观点评述


Papers by Dr. Tingdong Zhang and colleagues on the treatment of acute promyelocytic leukemia (APL) by arsenic trioxide



Treatment of acute promyelocytic leukemia (APL) has been significantly improved through the introduction of cytarabine by Ellison et al. in 1968, daunorubicin by Boiron et al. in 1969, arsenic trioxide by Zhang et al. in 1973 and all-trans retinoic acid by Huang et al. in 1987.

Least known among these is the pioneering research of Dr. Tingdong Zhang and colleagues: not a single English paper has cited their important original papers on arsenic trioxide in the 1970s.

To help alleviate this problem, I have listed here some of the publications of Dr. Zhang and his colleagues, with links to PDF files. I recommend that future publications on APL or arsenic trioxide cite Zhang et al. (1973), and Zhang and Rong (1979).

It should be clear from the documented literature that Tingdong Zhang played a pivotal role throughout these studies, with different collaborators contributing to some aspects, but not all, of this line of research. Only Zhang contributed to every key step of this work as well as the entire project.

There have been efforts in China to use traditional Chinese medical recipes that contain arsenic sulfate, but to date, these recipes have not been reduced to single chemicals and the exact relationship of those recipes to arsenic trioxide remains unclear.Thus, work by Zhang and colleagues on arsenic trioxide stands out from these other efforts in its singular success of transforming multiple starting materials into a defined molecule. 

What follows are the information for citation, PDF files, brief summaries and background of some of the major papers.

早幼粒细胞白血病APL的治疗有显著改善, 归功于Ellison等(1968)引入cytarabine, Boiron等(1969)引入daunorubicin, 张亭栋等(1973)引入三氧化二砷, 王振义课题组以黄等(1987)发表的论文引入全反型维甲酸 。








Zhang TD, Zhang PF, Wang SR, and Han TY (1973). Preliminary clinical observations of 6 cases of leukemia treated by “Ailin solution”. Med Pharm Heilongjiang 1973(3):66-67 (张亭栋,张鹏飞,王守仁,韩太云(1973) “癌灵注射液”治疗6例白血病初步临床观察.黑龙江医药 1973(3):66-67).

PDF:1973 Zhang TD_ Zhang PF_ Wang SR_ and Han TY.pdf

Summary and Background

In this paper, Zhang TD, Zhang PF, Wang and Han reported that they had used “Ailin solution” (also known as “Ailin I”) to treat six cases of chronic granulocytic leukemia. It explicitly stated that the components of the solution were arsenic trioxide and a trace amount of mercury chloride. All six improved after the treatment. It also mentioned that the authors were testing acute leukemia patients.

Before this paper, Taiyun Han, a pharmacist at the First Affiliated Hospital of Harbin Medical University, had learned that a country doctor practicing traditional Chinese medicine had used a combination of arsenic,mercury and toad venom to treat lymphatic tuberculosis and cancers. In March 1971, Han dissolved the three components in a solution, which he called“713” (after the year and month of his preparation) or “Ailin (literally meaning cancer effective)”. This was injected intramuscularly into patients, showing effects in some cancer patients. It was hotly sought after by local population, but soon abandoned because of its toxicity. Han neither defined the exact disease(s) that Ailin was against nor revealed the effective component among the several starting materials in Ailin.

Tingdong Zhang was a medical doctor in the same hospital as Han. Zhang was initially asked by the Health Bureau of Heilongjiang province to examine the validity of the claims of the countryside practitioner and later collaborated with Han.

This paper was thus a collaboration of Zhang, Han and others. On the one hand, rather than working with a variety of diseases ranging from tuberculosis to multiple types of cancers, Zhang et al. (1973) targeted leukemia. On the other hand, Zhang et al. (1973) used blood analysis, elevating the standard for measuring treatment success, which was not used by country practitioners of traditional Chinese medicine.






Departments of Traditional Chinese Medicine and Laboratory Medicine of the First Affiliated Hospital of Harbin Medical University (1974). Therapeutic observations of 17 cases leukemia treated with Ailin No.1 and dialectic theory. J Harbin Med Univ 1974(2):25-30 (哈医大一院中医科,哈医大一院检验科(1974). 癌灵1号注射液与辨证论治对17例白血病的疗效观察. 哈医大学报 1974(2):25-30).

PDF:1974 癌灵1号注射液与辨证论治对17例白血病的疗效观察 哈医大学报 25-30.pdf


This paper summarized the treatment of 17 cases of leukemia patients from January 1973 to April 1974. After going through different types of leukemia,they reported that Ailin I was effective in treating multiple types of leukemia, leading to complete remission  in acute leukemia patients.

In a separate 1976 paper not listed here, they used institutional authorship to publish a report on five cases of acute leukemia in which they had achieved complete remission.





Rong FX and Zhang TD (1979). A report on long term survival of 2 cases of acute granulocytic leukemia. J New Med Pharm 1979(6):31-34 (荣福祥,张亭栋(1979). 急性粒细胞性白血病长期存活2例报告. 新医药学杂志 1979(6):31-34).

PDF:1979 Rong & Zhang 急性粒细胞性白血病长期存活2例报告.pdf


This paper reported two acute granulocytic leukemia cases, one with complete remission for four and half and the other for three years.



Zhang TD and Rong FX (1979). Treatment of acute granulocytic leukemia by Ailin No.1 and dialectic theory. Medicine and Pharmacy of Heilongjiang 1979(4):7-11 (张亭栋和荣福祥(1979).癌灵一号注射液与辩证论治治疗急性粒细胞型白血病. 黑龙江医药 1979(4):7-11).

PDF:1979 Zhang & Rong 癌灵一号注射液与辨证论治治疗急性粒细胞型白血病.pdf


This paper summarized 55 cases of acute leukemia. 23 patients were treated with Ailin I alone (from 1973 to 1974), 20 patients treated with Ailin I in combination with Western chemotherapy and other Chinese medicines from 1975 to 1976, and 12 cases treated with Ailin I plus other Chinese medicines and chemotherapy from 1977 to 1978. For each patient, the authors presented leukemia subtypes and clinical observations. All 55 cases improved to some extent, with a remission rate of 70% and with complete remission in 12 cases. The side effect was small with the doses they used. The authors then applied 10 times the equivalent of what they used for adult human patients into 12 rabbits. No toxicity was observed in the heart, the liver,the spleen or the kidney of the rabbits.

Zhang and Rong (1979) explicitly stated that:1)significant improvement was observed in three patients(one adult and two children) treated with only Ailin I, but no other Western or Chinese drugs. At the time of publication, the children had survived for more than 4 years and the adult more than 9 months. When using other Chinese medicines, Zhang and Rong pointed out that those were not used for treating leukemia, but for supporting the general health of the patients so that they could tolerate more treatment; 2)the effective component of Ailin I was arsenic trioxide (on page 11 of their paper); 3)acute granulocytic leukemia (M3 type of the French-American British FAB classification, also known as APL) was the most sensitive to the treatment, which they reiterated on pages 10 and 11.

Therefore, it can be concluded that, by 1979, Zhang and his collaborators had clearly reached our current understanding: that arsenic trioxide can treat leukemia, especially the M3 subtype or APL.

Zhang et al. (1973) was the pioneering paper, beginning to study the effect of arsenic trioxide on leukemia (but tested only chronic leukemia), while Zhang and Rong (1979) was the most representative paper. Zhang and Rong (1973) made it clear that 1) only arsenic trioxide was required for the treatment; 2) the most sensitive leukemia was the M3 subtype of leukemia (also known as APL).

While different collaborators were involved in 1973, 1974 and 1979, only Tingdong Zhang was always involved and was always a major author, thus establishing his key role in this series of research.


张亭栋和荣福祥(1979)明确指出:1)有三例病人(一位成人、两位儿童),单纯使用“癌灵一号”,不用其他中药、不用化疗西药,也显示疗效,其中当时儿童存活已经4年,成人已存活9个月。在使用其他中药时,他们也指出其他中药并非治疗白血病、而用来支撑病人身体状况;2)在第11页,他们指出“癌灵一号”之有效成分为三氧化二砷;3)在第10页和第11页,他们两次明确指出对早幼粒型白血病效果最好。也就是说,1973年到1979年,张亭栋与不同的同事合作发表的论文,清晰地得到了我们今天的认识:三氧化二砷可以治疗白血病,特别是急性早幼粒白血病(法国-美国-英国FAB分型的M3型白血病,也即acute promyelocytic leukemia,APL)。

1973年的论文是他们发现“癌灵一号”的开创性论文,开始将砒霜用于白血病(但当时只报道了慢性白血病),而张亭栋与荣福祥(1979)是他们这一系列工作的代表性论文。张亭栋与荣福祥(1979) 论文已经明确:1)癌灵一号只需要三氧化二砷起治疗作用;2)最敏感的白血病是M3型的急性粒细胞白血病(后来也称为APL)。


Department of Traditional Chinese Medicine of the First Affiliated Hospital of Harbin Medical University (supervisor Zhang TD, writers Li YS, Hu XC, participants Li MX, Zhang PF, Rong FX, Sun HD, Li HR, Wu YX) (1981) A clinical summary of 73 cases treated by Ailin No.1 combined with the dialectic theory. Chinese Medicine and Pharmacy of Heilongjiang 1981(4):28-30 (哈尔滨医科大学附属第一医院中医科 (指导:张亭栋 执笔: 李元善 胡晓晨 参加人:李明祥 张鹏飞 荣福祥 孙洪德 李会荣 吴云霞 检验科血研究室)(1981)癌灵一号结合辨证施治治疗急性粒细胞型白血病73例临床小结. 黑龙江中医药 1981(4):28-30).
Summary and background:
This paper, though under an institutional authorship, came with a footnote indicating Zhang as the supervisor (with 8 other authors). It reported 73 cases of acute granulocytic leukemia patients, with complete remission of 24% and remission rate of 86%。
Not listed here was a related report in 1982, in which Zhang and Li gave a talk to a national meeting on 22 cases of complete remission by Ailin I and on 98 cases of non-lymphatic leukemia. 

1981年哈尔滨医科大学附属第一医院中医科 (文章最后注脚标明 指导:张亭栋;执笔:李元善,胡晓晨;参加人:李明祥,张鹏飞,荣福祥,孙洪德,李会荣,吴云霞,检验科血研究室)报道“癌灵一号”对急性粒细胞白血病完全缓解率达24%、总缓解率达86%。



Zhang TD (1982). Comments on questions about designing clinical research with combined Chinese and Western medicine. J Integrat Trad Chin West Med 2:180-181 (张亭栋 (1982) 谈谈中西医结合临床科研设计中的几个问题. 中西医结合杂志2:180-181).

PDF:1982 Zhang 谈谈中西医结合临床科研设计中的几个问题.pdf

Zhang published a commentary on his work.


Zhang TD (1983). Understanding and treatment of leukemia by Chinese Medicine. J Trad Chin Med 1983(3):71-74 (张亭栋 (1983) 中医对白血病的认识和治疗. 中医杂志 1983(3):71-74).

PDF:1983 Zhang 中医对白血病的认识和治疗.pdf

Zhang published a commentary on leukemia treatment. 


Zhang TD, Li YS (1984). Clinical findings and experimental research of Ailin No. 1 in treating acute granuloleukemia. J Integrat Trad Chin West Med 4:19-20 (张亭栋,李元善(1984). 癌灵1号治疗急性粒细胞白血病临床发现和实验研究。 中西医结合杂志4:19-20).
Zhang and Li published a summary of 81 cases whom they had treated since 1971. Among the 22 cases of complete remission, they pointed out that 7 were of the M2 type and 15 were of the M3 type. They again stated that the therapeutic effect on M3 type were particularly obvious.



Zhang TD (1985). Diagnosis and treatment of acute non-lymphatic leukemia. J Integrat Trad Chin West Med 5:713 (张亭栋 (1985) 急性非淋巴细胞性白血病证治. 中西医结合杂志 5: 713). 
 Zhang published another paper on the effect of Ailin I on non-lymphatic acute leukemia. 


Sun HD Ma L Hu XC Zhang TD, Rong FX, Wang QH, Li JM and Feng XQ (1991). Areport on 16 acute promyelocytic leukemia cases of long term survival treated by Ailin No.1 in combination with traditional Chinese dialectic theories. Info Trad Chin Med Pharm 1991(6):39-41 (孙鸿德,马玲,胡晓晨,张亭栋,荣福祥,王钦华,李金梅,冯秀芹 (1991) 癌灵1号结合中医辨证施治急性早幼粒白血病长期存活16例报告. 中医药信息 1991(6):39-41).

PDF:1991 Sun et al 癌灵1号结合中医辨证施治急性早幼粒细胞白血病长期存活16例报告.pdf


Sun, Ma, Hu, Zhang, Rong, Wang, Li and Hong reported 16 cases of APL. This was a continuation of Zhang and Li (1984). It reported that Ailin I had been used to treat 32 APL cases from 1974 to 1985, with complete remission in 19 cases and that 16 cases had survived for more than 5 years.



Sun HD Ma L Hu XC Zhang TD (1992). Ai-Lin I treated 32 cases of acute promyelocytic leukemia. Chin J Integrat Chin & West Med 12:170-172 (孙鸿德,马玲,胡晓晨,张亭栋 (1992).癌灵1号结合中医辨证治疗急性早幼粒白血病32例. 中国中西医结合杂志 12:170-171).

PDF:1992 Sun et al 癌灵1号结合中医辨证治疗急性早幼粒细胞白血病32例.pdf


Sun, Ma, Hu and Zhang published this short paper as “Sharing Experience”,reviewing materials identical to those in the 1991 paper. Strangely, most English papers cite this 1992 paper for the discovery of arsenic trioxide treatment of APL. Both the 1991 and the 1992 papers were in Chinese. The key findings were published in Zhang et al. (1973) and the effect on APL was clear in Zhang and Rong (1979). The often cited 1992 paper of Sun et al.(1992) was not substantially different from that of 1979, in either the chemicals applied or the subtype of leukemia treated. There is no scientific reason why Sun et al. (1992) was cited instead of the other papers prior to 1992.

孙鸿德、马玲、胡晓晨、张亭栋这篇作为“经验交流”发表的短文,实质相同于1991年论文。比较奇怪的是,英文文献引用这篇文章。该文与1991年论文一样都是中文,内容不过是1991年论文的简介,而实际发现最早发表于张亭栋等(1973),到张亭栋和荣福祥(1979)已明确了对APL的作用最好。而1992的论文在本质上与1979年的文章无差别,既没有改变所用的药物成分、也没有改变适应症。 没有科学理由引用孙鸿德等(1992)而不引用张亭栋等(1973)、或张亭栋与荣福祥(1979)。



Zhang P, Wang SY, Hu LH, Shi FD, Qiu FQ, Hong LJ, Han XY, Yang HF, Song YZ,Liu YP, Zhou J, Jin ZJ (1996) Treatment of 72 cases of acute promyelocytic leukemia with intravenous arsenic trioxide. Chin. J. Hematol. 17:58–62 (张鹏,王树叶,胡龙虎,施福东,邱凤琴,洪珞珈,韩雪英,杨惠芬,宋颖昭,刘艳平,周晋,金镇敬(1996)三氧化二砷注射液治疗72例急性早幼粒细胞白血病.中华血液学杂志 17:58-60).

PDF:1996 张鹏 et al 三氧化二砷注射液治疗72例急性早幼粒细胞白血病.pdf


Peng Zhang et al. from the same hospital as Tingdong Zhang published their use of arsenic trioxide in treating 72 APL cases. It summarized their experience of using arsenic trioxide alone (without a trace amount of mercury) in 130 APL cases from 1992 to 1995, among which 72 went through one or more course of treatment. A complete remission of 73% was reported for patients undergoing initial treatments and 52% in recurrent patients. No cross-resistance was observed between arsenic trioxide and all trans-retinoic acid.




Li YS, Zhang TD, Wang XR, Liu X (1988). Investigation of the dynamics of Ailin No. 1 on human liver cancer cells. Research on Cancer Prevention and Treatment. 15:1-3 (李元善,张亭栋,王兴榕,刘旭(1988). 癌灵1号注射液对人肝癌细胞杀伤动力学研究. 肿瘤防治研究 15:1-3).



Liu LX, Zhu AL, Chen W, Guo HX, Wang XQ, Liu ZH, Zhang TD, Jiang HC, Wu M(2005). Effect of arsenic trioxide on hepatocellular carcinoma and its mechanistic studies. Chin J Surg 43:33-36.(三氧化二砷治疗肝细胞肝癌及其机理研究. 中华外科杂志)

PDF:2005 三氧化二砷对原发性肝癌的作用及其机理研究.pdf



Guo HX, Chen W, Liu LX, Zhang TD (2006). Recent status of the effect of arsenic trioxide on colon cancer. Chin J Integr Trad West Med Dig 14:207-209.(三氧化二砷治疗结肠癌现状 中西医结合杂志)

PDF:2006 三氧化二砷对结肠癌作用的研究近况.pdf




收藏 IP: 202.66.131.*| 热度|

129 顾伯洪 孙玉涛 虞忠衡 吴飞鹏 马建敏 潘寄青 张卫 喻海良 刘立 张龙现 刘宝良 罗德海 杨宁 杨亚军 唐凌峰 李土荣 冯金华 吴耿 梁大成 许先进 王府民 徐晓 赵立平 梁建华 王大辉 张明 朱志敏 刘锋 常顺利 张业明 王明明 王志坚 徐长庆 王锋 熊祎 李宁 王华民 闵应骅 张用友 褚昭明 牛丕业 刘俊华 陈智文 于涛 宁利中 赫荣乔 石磊 杨洪强 杨立泉 毛培宏 李伟钢 刘士勇 魏晖 王汀 刘继顺 马红孺 张永华 范鹏贤 曹裕波 陈冬生 谢雪梅 钱李仁 戴德昌 贺乐 郭保华 张平 张海霞 贾伟 吴明火 周明明 尚书勇 金拓 汤亮 王守业 许稹 陈筝 彭思龙 茹永新 陈绍云 王宇澄 张志强 胡传圣 杨月琴 袁圳伟 朱建裕 徐向田 张炜平 蔡志全 孙亮 曹冲 zhanghuatian 笑傲江湖 westmidlands TLee mssy cloudyou boye schist xqhuang bridgeneer hengy thinpig hillyuan htysth sytw zhan0394 zxk730 mreric davos luyouwen crossludo wiseflower jiaohuping xuewu zuoluoz zzjtcm sci789789789 zhokzhok xiaoyu8 小木虫 wenbo88818 limits999 Majorite ahsys arsian coldeagle biofans GANSULANZHOU bukexiao

该博文允许注册用户评论 请点击登录 评论 (115 个评论)


Archiver|手机版|科学网 ( 京ICP备07017567号-12 )

GMT+8, 2023-3-27 21:41

Powered by ScienceNet.cn

Copyright © 2007- 中国科学报社